Ischemic Heart Disease Market of Middle-East and Africa to Arise at a CAGR of 3.1% by 2022

Ischemic heart Disease Market Information of Middle-East and Africa, by Type (stable angina, unstable angina, myocardial infarction, and Others) by Diagnosis (Electrocardiogram, Echocardiography, Stress Testing, Coronary angiography, Magnetic resonance imaging (MRI), Chest X Ray, and Others), by Treatment type (Medications, Surgery, Lifestyle changes, and others) - Forecast to 2022

Ischemic heart disease, also known as Coronary Artery Disease, is a condition that affects the supply of blood to the heart. The blood vessels are narrowed or blocked due to the deposition of cholesterol on their walls. The prevalence of coronary heart disease is promoted in turn by a high prevalence of cardiovascular risk factors, particularly smoking, hypertension, dyslipidemia, diabetes, and sedentary lifestyles.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2585 .

The market is growing at the CAGR of 3.1% and expected to reach to US$ 2.84 billion by 2022.

Countries in Middle East and Africa bear a heavy burden from Ischemic heart disease. According to, Dubai Health Authority, Heart disease is the cause for every 3 in 10 deaths in the UAE. Huge funding in R&D and various initiatives by government are driving the growth for Ischemic heart Disease Market in Middle East and Africa. Middle-East and Africa Ischemic heart Disease Market is growing steadily.

Key Players for Middle-East and Africa Ischemic heart Disease Market:

Some of the key players in this market are: King Faisal Specialist Hospital and Research Centre (Saudi Arabia), Riyadh Military Hospital (Saudi Arabia), Hamad Medical Corporation (Qatar), American Hospital Dubai, Ganzouri Specialized Hospital (Egypt), AstraZeneca (U.K.), Sanofi (France), Merck Sharp & Dohme Corp.(U.S.), AUM Cardiovascular (US), HeartWare (U.S.).

Market Segments:

Middle-East and Africa Ischemic heart Disease Market has been segmented on the basis of type which comprise stable angina, unstable angina, myocardial infarction, and Others. On the basis of diagnosis the market is segmented into (Electrocardiogram, Echocardiography, Stress Testing, Coronary angiography, Magnetic resonance imaging (MRI), Chest X Ray, and Others. On the basis of treatment type market is segmented into Medications, Surgery, Lifestyle changes, and others.

Browse Report @ https://www.marketresearchfuture.com/reports/mea-ischemic-heart-disease-market-2585 .

Regional Analysis of Middle-East and Africa Ischemic heart Disease Market:

Considering the Middle-East and Africa Ischemic heart Disease Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Ischemic heart Disease. Moreover Saudi Arabia market is also growing and second largest market for Ischemic heart disease. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Ischemic heart Disease during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market. The report for Middle-East and Africa Ischemic heart Disease Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance.

Study objectives of Middle-East and Africa Ischemic heart Disease Market:

To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the Middle-East and Africa Ischemic heart Disease Market. Provide insights about factors affecting the market growth. Analyze the Middle-East and Africa Ischemic heart Disease Market based on various factors- price analysis, supply chain analysis, porters five force analysis etc. Provide historical and forecast revenue of the market segments and sub-segments with respect to two main geographies and their countries- Middle East & Africa. Provide country level analysis of the market with respect to the current market size and future prospective. Provide country level analysis of the market for segments by type, by diagnosis, by treatment type and its sub-segments. Provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market. Track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Middle-East and Africa Ischemic heart Disease Market.

Get Discount @ https://www.marketresearchfuture.com/check-discount/2585 .

Table of Content:

1. Report Prologue
2. Introduction
3. Research Methodology
4. Market Dynamics
5. Market Factor Analysis
6. Middle-East and Africa Ischemic Heart Disease Market by Type
7. Middle-East and Africa Ischemic Heart Disease Market by Diagnosis
8. Middle-East and Africa Ischemic Heart Disease Market by Treatment Type
8. Middle-East and Africa Ischemic Heart Disease Market by Region

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for , regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

This release was published on openPR.